Listed

Envoy Medical, Inc.

COCHNasdaqCIK 1840877HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$51.0k, Q2 FY2026
Operating income−$5.6m, Q2 FY2026
Net income−$6.0m, Q2 FY2026
Envoy Medical, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$k80.0Revenue, Q3 FY2023, three months to 2023-09-30$80.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-14, accession 0001213900-24-097861.Report this figure95.0Revenue, Q4 FY2023, three months to 2023-12-31$95.0k. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-31, accession 0001013762-25-004299. Derived: 12-month figure less the 9-month figure.Report this figure59.0Revenue, Q1 FY2024, three months to 2024-03-31$59.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure68.0Revenue, Q2 FY2024, three months to 2024-06-30$68.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-07-31, accession 0001213900-25-069663.Report this figure56.0Revenue, Q3 FY2024, three months to 2024-09-30$56.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure42.0Revenue, Q4 FY2024, three months to 2024-12-31$42.0k. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figure46.0Revenue, Q1 FY2025, three months to 2025-03-31$46.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure78.0Revenue, Q2 FY2025, three months to 2025-06-30$78.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure42.0Revenue, Q3 FY2025, three months to 2025-09-30$42.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure75.0Revenue, Q4 FY2025, three months to 2025-12-31$75.0k. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figure39.0Revenue, Q1 FY2026, three months to 2026-03-31$39.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure51.0Revenue, Q2 FY2026, three months to 2026-06-30$51.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure
Cost of revenue$k189Cost of revenue, Q3 FY2023, three months to 2023-09-30$189.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-14, accession 0001213900-24-097861.Report this figure234Cost of revenue, Q4 FY2023, three months to 2023-12-31$234.0k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-31, accession 0001013762-25-004299. Derived: 12-month figure less the 9-month figure.Report this figure153Cost of revenue, Q1 FY2024, three months to 2024-03-31$153.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure245Cost of revenue, Q2 FY2024, three months to 2024-06-30$245.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-31, accession 0001213900-25-069663.Report this figure187Cost of revenue, Q3 FY2024, three months to 2024-09-30$187.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure157Cost of revenue, Q4 FY2024, three months to 2024-12-31$157.0k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-31, accession 0001013762-25-004299. Derived: 12-month figure less the 9-month figure.Report this figure226Cost of revenue, Q1 FY2025, three months to 2025-03-31$226.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure234Cost of revenue, Q2 FY2025, three months to 2025-06-30$234.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure203Cost of revenue, Q3 FY2025, three months to 2025-09-30$203.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure211Cost of revenue, Q4 FY2025, three months to 2025-12-31$211.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figure313Cost of revenue, Q1 FY2026, three months to 2026-03-31$313.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure278Cost of revenue, Q2 FY2026, three months to 2026-06-30$278.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure
Research and development$k1,850Research and development, Q3 FY2023, three months to 2023-09-30$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001213900-24-097861.Report this figure3,055Research and development, Q4 FY2023, three months to 2023-12-31$3.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001013762-25-004299. Derived: 12-month figure less the 9-month figure.Report this figure2,360Research and development, Q1 FY2024, three months to 2024-03-31$2.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure2,591Research and development, Q2 FY2024, three months to 2024-06-30$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-31, accession 0001213900-25-069663.Report this figure2,757Research and development, Q3 FY2024, three months to 2024-09-30$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure2,471Research and development, Q4 FY2024, three months to 2024-12-31$2.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figure2,748Research and development, Q1 FY2025, three months to 2025-03-31$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure2,485Research and development, Q2 FY2025, three months to 2025-06-30$2.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure2,700Research and development, Q3 FY2025, three months to 2025-09-30$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure4,553Research and development, Q4 FY2025, three months to 2025-12-31$4.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figure3,642Research and development, Q1 FY2026, three months to 2026-03-31$3.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure3,132Research and development, Q2 FY2026, three months to 2026-06-30$3.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure
Selling, general and administrative$k1,426Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$1.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q/A filed 2024-01-17, accession 0001213900-24-004149.Report this figure1,875Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2024-04-01, accession 0001213900-24-028894. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$k(3,385)Operating income, Q3 FY2023, three months to 2023-09-30−$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001213900-24-097861.Report this figure(6,723)Operating income, Q4 FY2023, three months to 2023-12-31−$6.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001013762-25-004299. Derived: 12-month figure less the 9-month figure.Report this figure(4,884)Operating income, Q1 FY2024, three months to 2024-03-31−$4.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure(4,852)Operating income, Q2 FY2024, three months to 2024-06-30−$4.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-31, accession 0001213900-25-069663.Report this figure(4,972)Operating income, Q3 FY2024, three months to 2024-09-30−$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure(4,549)Operating income, Q4 FY2024, three months to 2024-12-31−$4.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figure(5,107)Operating income, Q1 FY2025, three months to 2025-03-31−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure(5,070)Operating income, Q2 FY2025, three months to 2025-06-30−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure(5,708)Operating income, Q3 FY2025, three months to 2025-09-30−$5.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure(6,385)Operating income, Q4 FY2025, three months to 2025-12-31−$6.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figure(5,959)Operating income, Q1 FY2026, three months to 2026-03-31−$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure(5,569)Operating income, Q2 FY2026, three months to 2026-06-30−$5.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure
Interest expense$knot reportednot reported36.0Interest expense, Q1 FY2024, three months to 2024-03-31$36.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure132Interest expense, Q2 FY2024, three months to 2024-06-30$132.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-07-31, accession 0001213900-25-069663.Report this figure264Interest expense, Q3 FY2024, three months to 2024-09-30$264.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure384Interest expense, Q4 FY2024, three months to 2024-12-31$384.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figure495Interest expense, Q1 FY2025, three months to 2025-03-31$495.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure624Interest expense, Q2 FY2025, three months to 2025-06-30$624.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure471Interest expense, Q3 FY2025, three months to 2025-09-30$471.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Income tax$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$k1,563Net income, Q3 FY2023, three months to 2023-09-30$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001213900-24-097861.Report this figure(4,895)Net income, Q4 FY2023, three months to 2023-12-31−$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001013762-25-004299. Derived: 12-month figure less the 9-month figure.Report this figure(6,270)Net income, Q1 FY2024, three months to 2024-03-31−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure(3,947)Net income, Q2 FY2024, three months to 2024-06-30−$3.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure(5,960)Net income, Q3 FY2024, three months to 2024-09-30−$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure(4,618)Net income, Q4 FY2024, three months to 2024-12-31−$4.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figure(4,998)Net income, Q1 FY2025, three months to 2025-03-31−$5.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure(5,690)Net income, Q2 FY2025, three months to 2025-06-30−$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure(6,482)Net income, Q3 FY2025, three months to 2025-09-30−$6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure(6,586)Net income, Q4 FY2025, three months to 2025-12-31−$6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figure(4,351)Net income, Q1 FY2026, three months to 2026-03-31−$4.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure(5,982)Net income, Q2 FY2026, three months to 2026-06-30−$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure
Diluted EPS$ per share0.13Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001213900-24-097861.Report this figurenot reported(0.41)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure(0.29)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-31, accession 0001213900-25-069663.Report this figure(0.39)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figurenot reported(0.29)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure(0.32)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure(0.35)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figurenot reported(0.08)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure(0.07)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure
Basic EPS$ per share0.13Basic EPS, Q3 FY2023, three months to 2023-09-30$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001213900-24-097861.Report this figurenot reported(0.41)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure(0.29)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-31, accession 0001213900-25-069663.Report this figure(0.39)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figurenot reported(0.29)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure(0.32)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure(0.35)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figurenot reported(0.08)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure(0.07)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure

Balance sheet

Cash and equivalents$19.7m, Q2 FY2026
Shareholders' equity$3.3m, Q2 FY2026
Envoy Medical, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m7.4Cash and equivalents, Q3 FY2023, at 2023-09-30$7.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q/A filed 2024-01-17, accession 0001213900-24-004149.Report this figure4.2Cash and equivalents, FY2023, at 2023-12-31$4.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2024-04-01, accession 0001213900-24-028894.Report this figure4.9Cash and equivalents, Q1 FY2024, at 2024-03-31$4.9m. XBRL concept us-gaap:Cash. 10-Q filed 2024-05-15, accession 0001213900-24-043566.Report this figure1.7Cash and equivalents, Q2 FY2024, at 2024-06-30$1.7m. XBRL concept us-gaap:Cash. 10-Q filed 2024-08-12, accession 0001213900-24-067381.Report this figure4.4Cash and equivalents, Q3 FY2024, at 2024-09-30$4.4m. XBRL concept us-gaap:Cash. 10-Q filed 2024-11-14, accession 0001213900-24-097861.Report this figure5.5Cash and equivalents, FY2024, at 2024-12-31$5.5m. XBRL concept us-gaap:Cash. 10-K filed 2025-03-31, accession 0001013762-25-004299.Report this figure5.3Cash and equivalents, Q1 FY2025, at 2025-03-31$5.3m. XBRL concept us-gaap:Cash. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure5.3Cash and equivalents, Q2 FY2025, at 2025-06-30$5.3m. XBRL concept us-gaap:Cash. 10-Q filed 2025-07-31, accession 0001213900-25-069663.Report this figure3.6Cash and equivalents, Q3 FY2025, at 2025-09-30$3.6m. XBRL concept us-gaap:Cash. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure3.7Cash and equivalents, FY2025, at 2025-12-31$3.7m. XBRL concept us-gaap:Cash. 10-K filed 2026-03-23, accession 0001213900-26-032683.Report this figure25.3Cash and equivalents, Q1 FY2026, at 2026-03-31$25.3m. XBRL concept us-gaap:Cash. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure19.7Cash and equivalents, Q2 FY2026, at 2026-06-30$19.7m. XBRL concept us-gaap:Cash. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure
Current assets$m20.3Current assets, Q3 FY2023, at 2023-09-30$20.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2024-01-17, accession 0001213900-24-004149.Report this figure7.5Current assets, FY2023, at 2023-12-31$7.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001013762-25-004299.Report this figure7.7Current assets, Q1 FY2024, at 2024-03-31$7.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001213900-24-043566.Report this figure5.0Current assets, Q2 FY2024, at 2024-06-30$5.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0001213900-24-067381.Report this figure7.1Current assets, Q3 FY2024, at 2024-09-30$7.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001213900-24-097861.Report this figure8.9Current assets, FY2024, at 2024-12-31$8.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-23, accession 0001213900-26-032683.Report this figure8.3Current assets, Q1 FY2025, at 2025-03-31$8.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure7.5Current assets, Q2 FY2025, at 2025-06-30$7.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-31, accession 0001213900-25-069663.Report this figure5.8Current assets, Q3 FY2025, at 2025-09-30$5.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure6.3Current assets, FY2025, at 2025-12-31$6.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure27.7Current assets, Q1 FY2026, at 2026-03-31$27.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure21.9Current assets, Q2 FY2026, at 2026-06-30$21.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure
Total assets$m21.2Total assets, Q3 FY2023, at 2023-09-30$21.2m. XBRL concept us-gaap:Assets. 10-Q/A filed 2024-01-17, accession 0001213900-24-004149.Report this figure8.3Total assets, FY2023, at 2023-12-31$8.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001013762-25-004299.Report this figure8.5Total assets, Q1 FY2024, at 2024-03-31$8.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001213900-24-043566.Report this figure6.7Total assets, Q2 FY2024, at 2024-06-30$6.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0001213900-24-067381.Report this figure9.4Total assets, Q3 FY2024, at 2024-09-30$9.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001213900-24-097861.Report this figure11.5Total assets, FY2024, at 2024-12-31$11.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-23, accession 0001213900-26-032683.Report this figure10.4Total assets, Q1 FY2025, at 2025-03-31$10.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure9.9Total assets, Q2 FY2025, at 2025-06-30$9.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-31, accession 0001213900-25-069663.Report this figure8.2Total assets, Q3 FY2025, at 2025-09-30$8.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure8.6Total assets, FY2025, at 2025-12-31$8.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure29.8Total assets, Q1 FY2026, at 2026-03-31$29.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure23.9Total assets, Q2 FY2026, at 2026-06-30$23.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure
Current liabilities$m12.7Current liabilities, Q3 FY2023, at 2023-09-30$12.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2024-01-17, accession 0001213900-24-004149.Report this figure7.3Current liabilities, FY2023, at 2023-12-31$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001013762-25-004299.Report this figure7.0Current liabilities, Q1 FY2024, at 2024-03-31$7.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001213900-24-043566.Report this figure8.1Current liabilities, Q2 FY2024, at 2024-06-30$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0001213900-24-067381.Report this figure9.1Current liabilities, Q3 FY2024, at 2024-09-30$9.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001213900-24-097861.Report this figure7.5Current liabilities, FY2024, at 2024-12-31$7.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-23, accession 0001213900-26-032683.Report this figure7.6Current liabilities, Q1 FY2025, at 2025-03-31$7.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure8.0Current liabilities, Q2 FY2025, at 2025-06-30$8.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-31, accession 0001213900-25-069663.Report this figure9.0Current liabilities, Q3 FY2025, at 2025-09-30$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure11.6Current liabilities, FY2025, at 2025-12-31$11.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure12.2Current liabilities, Q1 FY2026, at 2026-03-31$12.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure12.6Current liabilities, Q2 FY2026, at 2026-06-30$12.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure
Total liabilities$m16.4Total liabilities, Q3 FY2023, at 2023-09-30$16.4m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2024-01-17, accession 0001213900-24-004149.Report this figure10.0Total liabilities, FY2023, at 2023-12-31$10.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001013762-25-004299.Report this figure15.9Total liabilities, Q1 FY2024, at 2024-03-31$15.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001213900-24-043566.Report this figure19.1Total liabilities, Q2 FY2024, at 2024-06-30$19.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0001213900-24-067381.Report this figure27.9Total liabilities, Q3 FY2024, at 2024-09-30$27.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001213900-24-097861.Report this figure30.4Total liabilities, FY2024, at 2024-12-31$30.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-23, accession 0001213900-26-032683.Report this figure34.6Total liabilities, Q1 FY2025, at 2025-03-31$34.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure39.8Total liabilities, Q2 FY2025, at 2025-06-30$39.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-31, accession 0001213900-25-069663.Report this figure15.7Total liabilities, Q3 FY2025, at 2025-09-30$15.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure20.3Total liabilities, FY2025, at 2025-12-31$20.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure19.3Total liabilities, Q1 FY2026, at 2026-03-31$19.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure20.3Total liabilities, Q2 FY2026, at 2026-06-30$20.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure
Shareholders' equity$m4.8Shareholders' equity, Q3 FY2023, at 2023-09-30$4.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001213900-24-097861.Report this figure(1.8)Shareholders' equity, FY2023, at 2023-12-31−$1.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-23, accession 0001213900-26-032683.Report this figure(7.4)Shareholders' equity, Q1 FY2024, at 2024-03-31−$7.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure(12.4)Shareholders' equity, Q2 FY2024, at 2024-06-30−$12.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure(18.5)Shareholders' equity, Q3 FY2024, at 2024-09-30−$18.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure(18.8)Shareholders' equity, FY2024, at 2024-12-31−$18.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure(24.2)Shareholders' equity, Q1 FY2025, at 2025-03-31−$24.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure(29.9)Shareholders' equity, Q2 FY2025, at 2025-06-30−$29.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure(7.7)Shareholders' equity, Q3 FY2025, at 2025-09-30−$7.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure(12.2)Shareholders' equity, FY2025, at 2025-12-31−$12.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure10.2Shareholders' equity, Q1 FY2026, at 2026-03-31$10.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure3.3Shareholders' equity, Q2 FY2026, at 2026-06-30$3.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure

Cash flow

Operating cash flow−$5.5m, Q2 FY2026
Capital expenditure$172.0k, Q4 FY2025
Envoy Medical, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m1.1Operating cash flow, Q3 FY2023, three months to 2023-09-30$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001213900-24-097861. Derived: 9-month figure less the 6-month figure.Report this figure(11.1)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$11.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001013762-25-004299. Derived: 12-month figure less the 9-month figure.Report this figure(5.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$5.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure(4.6)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-31, accession 0001213900-25-069663. Derived: 6-month figure less the 3-month figure.Report this figure(2.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$2.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001213900-25-107902. Derived: 9-month figure less the 6-month figure.Report this figure(5.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$5.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figure(3.7)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$3.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure(4.5)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001213900-26-086974. Derived: 6-month figure less the 3-month figure.Report this figure(4.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001213900-25-107902. Derived: 9-month figure less the 6-month figure.Report this figure(5.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figure(6.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$6.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure(5.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$5.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001213900-26-086974. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$62.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001213900-24-097861. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$21.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001013762-25-004299. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$109.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure0.2Capital expenditure, Q2 FY2024, three months to 2024-06-30$248.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-31, accession 0001213900-25-069663. Derived: 6-month figure less the 3-month figure.Report this figure1.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001213900-25-107902. Derived: 9-month figure less the 6-month figure.Report this figure(0.5)Capital expenditure, Q4 FY2024, three months to 2024-12-31−$534.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001213900-26-086974. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001213900-25-107902. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$172.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Dividends paid$mnot reportednot reportednot reportednot reportednot reported0.6Dividends paid, Q4 FY2024, three months to 2024-12-31$614.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figure1.2Dividends paid, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure0.6Dividends paid, Q2 FY2025, three months to 2025-06-30$607.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2026-08-10, accession 0001213900-26-086974. Derived: 6-month figure less the 3-month figure.Report this figure0.0Dividends paid, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2025-11-10, accession 0001213900-25-107902. Derived: 9-month figure less the 6-month figure.Report this figure(0.0)Dividends paid, Q4 FY2025, three months to 2025-12-31−$1.0k. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2026-03-23, accession 0001213900-26-032683. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)104.04m, Q2 FY2026
Envoy Medical, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares10.1Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3010,123,187 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2024-01-17, accession 0001213900-24-004149.Report this figure10.1Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3110,122,581 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001213900-24-043566.Report this figure10.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3010,122,581 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0001213900-24-067381.Report this figure11.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3011,215,068 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001213900-24-097861.Report this figure18.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3118,599,982 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0001213900-25-038468.Report this figure18.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3018,599,982 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-31, accession 0001213900-25-069663.Report this figure18.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3018,616,362 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure21.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3121,326,609 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure21.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3021,383,852 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure21.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3021,851,606 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001213900-25-107902.Report this figure68.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3168,934,960 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001213900-26-054209.Report this figure104Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30104,039,109 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure

Shares outstanding: 77.19mShares outstanding, period not labelled, at 2026-08-1077,194,595 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-10, accession 0001213900-26-086974.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 10, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.